REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the ...

Alvotech ( NASDAQ:ALVO ) just reported some strong earnings, and the market reacted accordingly with a healthy ...

Selardsdi is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

Good day, and thank you for standing by. Welcome to the Alvotech Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation ...

Learn more about whether Alvotech or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

It announces that Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech, has acquired 210,000 shares at ISK 1,277.38 each. The largest shareholders in Alvogen Lux Holdings are ...

REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients ...

It's been a pretty great week for Alvotech (NASDAQ:ALVO) shareholders, with its shares surging 18% to US$9.68 in the week since its latest quarterly results. Revenues came in at US$133m, an impressive ...

We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Alvotech (NASDAQ:ALVO) stands against the other stocks ...

A recent filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) reveals that Robert Wessman, the Chairman and CEO of Alvotech, has acquired 320,000 shares of the company ...